Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00806091 · ClinicalTrials.gov registry record

Functional Proteomics of Alveolar Macrophages

A clinical trial of COPD, sponsored by Ohio State University.

Completed
Registry status
72
Enrollment target
1
Study location

NCT00806091: Completed study of COPD, sponsored by Ohio State University.

NCT00806091 is a study of COPD that has completed, run by Ohio State University. The registered enrollment target is 72 participants, below the 2,417-participant average among 85 other COPD trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00806091, a study of COPD, has completed, sponsored by Ohio State University.

COMPLETED
Registry status
72 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to obtain young white blood cells (monocytes) from the investigators donated blood for research into how these cells change into large, mature white blood cells (macrophages) and how smoking causes Chronic Obstructive Pulmonary Disease (COPD).

Conditions Studied

Study Locations (1)

Ohio

  • The Ohio State University - Columbus

Trial Details

FieldValue
Enrollment Target 72 participants
Start Date 2004-07
Est. Completion 2008-12
Ohio State University

552 total trials

What the finished NCT00806091 record still lists

NCT00806091 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 72 participants, a relatively small participant target, below the 2,417-participant average among 85 other COPD trials with a reported enrollment target (97% lower).

The record links to 1 condition, with COPD appearing as the primary indexed condition, and to 0 interventions.

NCT00806091 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT00806091 about?

NCT00806091 is a clinical study titled "Functional Proteomics of Alveolar Macrophages". The purpose of this study is to obtain young white blood cells (monocytes) from the investigators donated blood for research into how these cells change into large, mature white blood cells (macrophages) and how smoking causes Chronic Obstructive Pulmonary Disease (COPD).

What is the current status of trial NCT00806091?

This trial is currently completed. The enrollment target is 72 participants. The study started on 2004-07. Estimated completion is 2008-12.

What conditions does trial NCT00806091 study?

This clinical trial studies the following conditions: COPD.

Who is sponsoring clinical trial NCT00806091?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00806091 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for COPD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00806091's enrollment target sits among peer trials

72 44th of 85 higher than 42 of 85 other COPD trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other COPD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02359253 · 72 participants · NA

    Robot Aided Rehabilitation - Intervention

  • NCT02962661 · 72 participants · Phase 1

    Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines

  • NCT03113643 · 72 participants · Phase 1

    SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

  • NCT03187535 · 72 participants · NA

    Effect of TEAS on PONV After Spinal Surgery

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00806091, the US trial registry maintained by the National Library of Medicine. NCT00806091 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.